Home » Topics » Regulatory

Regulatory
RSS

Biocon receives marketing authorization in India for itolizumab

Jan. 10, 2013

FDA approves Kineret for the treatment of NOMID

Jan. 10, 2013

FDA approves Fulyzaq for diarrhea in patients with HIV/AIDS

Jan. 2, 2013

FDA grants accelerated approval for Sirturo in tuberculosis

Jan. 2, 2013

FDA approves Juxtapid for homozygous familial hypercholesterolemia

Dec. 27, 2012

FDA expands approval of Tamiflu

Dec. 24, 2012

FDA approves Biotest's IVIG for primary humoral immunodeficiency

Dec. 21, 2012

GSK's four-strain seasonal influenza vaccine Fluarix Quadrivalent approved for use in U.S.

Dec. 18, 2012

FDA approves GSK's raxibacumab for inhalational anthrax

Dec. 17, 2012

FDA expands indication for Zytiga

Dec. 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...